共 50 条
Structural characterization and antiviral activity of two fucoidans from the brown algae Sargassum henslowianum
被引:71
|作者:
Sun, Qi-Li
[1
,4
]
Li, Yi
[2
,3
]
Ni, Long-Quan
[2
,3
]
Li, Yi-Xuan
[1
,4
]
Cui, Yong-Sheng
[1
]
Jiang, Si-Liang
[1
,4
]
Xie, En-Yi
[5
]
Du, Juan
[4
]
Deng, Fei
[2
,3
]
Dong, Cai-Xia
[1
]
机构:
[1] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
[2] Chinese Acad Sci, Wuhan Inst Virol, State Kay Lab Virol, Wuhan 430071, Hubei, Peoples R China
[3] Chinese Acad Sci, Wuhan Inst Virol, Natl Virus Resource Ctr, Wuhan 430071, Hubei, Peoples R China
[4] Jiamusi Univ, Coll Pharm, Dept Pharmacognosy, Jiamusi 154007, Peoples R China
[5] Guangdong Ocean Univ, Coll Fisheries, Zhanjiang 524088, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Brown algae;
Sargassum henslowianum;
Fucoidans;
Antiviral;
Herpes simplex virus;
WATER-SOLUBLE POLYSACCHARIDES;
ACTIVITY IN-VITRO;
SULFATED POLYSACCHARIDE;
SEAWEED SARGASSUM;
GENITAL HERPES;
ANTIINFLAMMATORY ACTIVITY;
ANTICANCER;
GALACTOFUCAN;
ANTIOXIDANT;
FUCANS;
D O I:
10.1016/j.carbpol.2019.115487
中图分类号:
O69 [应用化学];
学科分类号:
081704 ;
摘要:
Purified fucoidans SHAP-1 and SHAP-2 with apparent molecular weights of 6.55 x 10(5) and 5.89 x 10(5), respectively, were isolated from Sargassum henslowianum by ion-exchange and gel-filtration column chromatography. They are both composed of fucose and galactose at a ratio of around 3:1 and 31.9% sulfate. The backbone of two fucoidans consists of alpha-(1 -> 3)-linked L-Fucp residues which are mainly sulfated on the C-2 and C-4 positions. Side chains composed of terminally linked alpha-L-Fucp and alpha-D-Galp residues, and (1 -> 2)-, (1 -> 6)-, and (1 -> 2,6)-linked beta--Galp residues attach mainly at O-4 position of backbone residues. Antiviral test showed that the IC50 values of SHAP-1 and SHAP-2 against HSV-1 were estimated to be 0.89 and 0.82 mu g/mL by plaque reduction assay, respectively, whereas both as low as 0.48 mu g/mL against HSV-2. The antiviral mechanism of the fucoidans might be at least through blocking HSV-2 virion adsorption to host cells. These results suggest that the fucoidans have potential clinical applications.
引用
收藏
页数:10
相关论文